Key result
Substitution of phenylalanine 435 with glycine (F435G) facilitates hinge bending and leads to constitutively active Epac2, whereas substitution with tryptophan (F435W) impedes hinge motion.
Phenylalanine 435 is critical for maintaining Epac2 in a closed, inactive state in the absence of cAMP while allowing hinge motion for activation upon cAMP binding.
Answers are grounded in this paper and cite their sources.
Pinpoints Epac2 hinge regulation; hypothesis-generating for cAMP pathway modulation but requires validation before any cardiovascular application.
Epac2 is a member of the family of exchange proteins directly activated by cAMP (Epac). Our previous studies suggest a model of Epac activation in which cAMP binding to the enzyme induces a localized "hinge" motion that reorients the regulatory lobe relative to the catalytic lobe without inducing large conformational changes within individual lobes. In this study, we identified the location of the major hinge in Epac2 by normal mode motion correlation and structural alignment analyses. Targeted mutagenesis was then performed to test the functional importance of hinge bending for Epac activation. We show that substitution of the conserved residue phenylalanine 435 with glycine (F435G) facilitates the hinge bending and leads to a constitutively active Epac2 capable of stimulating nucleotide exchange in the absence of cAMP. In contrast, substitution of the same residue with a bulkier side chain, tryptophan (F435W), impedes the hinge motion and results in a dramatic decrease in Epac2 catalytic activity. Structural parameters determined by small angle x-ray scattering further reveal that whereas the F435G mutant assumes a more extended conformation in the absence of cAMP, the F435W mutant is incapable of adopting the fully extended and active conformation in the presence of cAMP. These findings demonstrate the importance of hinge motion in Epac activation. Our study also suggests that phenylalanine at position 435 is the optimal size side chain to keep Epac closed and inactive in the absence of cAMP while still allowing the proper hinge motion for full Epac extension and activation in the presence of cAMP.
No takes yet. Share an insight, caveat, or question.
Tsalkova et al. (2009) studied this question. Targeted mutagenesis (F435G and F435W) vs. Wild-type Epac2 was evaluated on Hinge bending and catalytic activity. Substitution of phenylalanine 435 with glycine (F435G) facilitates hinge bending and leads to constitutively active Epac2, whereas substitution with tryptophan (F435W) impedes hinge motion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: